Document is current
Any future updates will be listed below
-
Authors
Zhang, Shuyao
Sidra, Fnu
Alvarez, Carlos A.
Kinaan, Mustafa
Lingvay, Ildiko https://orcid.org/0000-0001-7006-7401
Mansi, Ishak A. https://orcid.org/0000-0001-6122-3716
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 28 October 2024
First Online: 5 December 2024
Competing interests
: I.L. received research funding (paid to institution) from NovoNordisk, Sanofi, Merck, Pfizer, Mylan, Boehringer-Ingelheim. IL received advisory/consulting fees and/or other support from: Novo Nordisk, Eli Lilly, Sanofi, Astra Zeneca, Boehringer-Ingelheim, Cytoki Pharma, Johnson and Johnson, Intercept, TARGETPharma, Merck, Pfizer, Valeritas, Zealand Pharma, Shionogi, Carmot Therapeutics, Structure Therapeutics, Bayer, Translational Medical Academy, Mediflix, Biomea, Metsera, Regeneron, The Comm Group, and WebMD. I.L. serves on the Data Safety Monitoring Board for JAEB. C.A.A. received research funding (paid to the institution) from Merck, Bristol Myers Squibb, and Boehringer-Ingelheim. C.A.A. received funding from the National Institutes of Health National Center for Advancing Translational Sciences (grant #UL1TR003163). S.Z., F.S. and I.A.M. declared no conflict of interest.
